D-Serine for Enhancing Cognitive Retraining for the Treatment of Schizophrenia

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2005

Conditions

SchizophreniaSchizoaffective Disorder

Interventions

DRUG

D-serine

BEHAVIORAL

Cognitive retraining

Trial Locations (1)

National Institute of Mental Health and Neurosciences, Bangalore

All Listed Sponsors

collaborator

Stanley Medical Research Institute

OTHER

collaborator

Donaghue Foundation

UNKNOWN

collaborator

US Department of Veterans Affairs

FED

collaborator

VA Office of Research and Development

FED

lead

Yale University

OTHER

NCT00237848 - D-Serine for Enhancing Cognitive Retraining for the Treatment of Schizophrenia | Biotech Hunter | Biotech Hunter